AMINO ACIDS, ARGINASE AND NITRIC OXIDE IN VASCULAR HEALTH
- 26 January 2006
- journal article
- review article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 33 (1-2) , 1-8
Abstract
1. Nitric oxide (NO) plays a fundamental role in the vasculature because of its diverse influence in vascular protection, including its well-reported antiproliferative, anti-inflammatory, antithrombotic and vasodilator effects. In many vascular disease states, NO production is reduced as a result of endothelial dysfunction, in part caused by a decrease in substrate (L-arginine) availability. 2. The role of L-arginine and other amino acids important in nitrogen balance has been re-examined in the context of their effects on vascular health. The metabolism of L-arginine is complex because it is involved in a plethora of other pathways, such as urea, creatine and agmatine production. L-Arginine supplementation in patients with vascular disease is well reported to benefit patients therapeutically because of its effect on both NO-dependent and -independent mechanisms. 3. L-Arginine availability depends on the flux of other amino acids in the body, including L-glutamine, L-glutamate, L-ornithine, L-citrulline and L-lysine. The role of L-methionine and homocystine and their effect on NO also play an influential role in the body. 4. Recent data suggest that the key enzyme involved in the L-arginine-urea cycle, arginase, is coexpressed in NO-producing cells in the vasculature. In the present review, we examine the potential role of arginase as a therapeutic target for vascular health.Keywords
This publication has 91 references indexed in Scilit:
- Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertensionThe FASEB Journal, 2004
- Asymmetric Dimethylarginine Produces Vascular Lesions in Endothelial Nitric Oxide Synthase–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Role of the nitric oxide-cyclic GMP pathway in regulation of vaginal blood flowInternational Journal Of Impotence Research, 2003
- Role of L‐arginine in the vascular actions and development of tolerance to nitroglycerinBritish Journal of Pharmacology, 2000
- Nω-Hydroxy-L-Arginine, an Intermediate in the L-Arginine to Nitric Oxide Pathway, Is a Strong Inhibitor of Liver and Macrophage ArginaseBiochemical and Biophysical Research Communications, 1994
- Inhibition of Rat Liver Arginase by an Intermediate in NO Biosynthesis, NG-Hydroxy-L-arginine: Implications for the Regulation of Nitric Oxide Biosynthesis by ArginaseBiochemical and Biophysical Research Communications, 1994
- Biochemical mechanism of organic nitrate actionThe American Journal of Cardiology, 1992
- Nitrate ToleranceDrugs, 1989
- The role of nitric oxide and cGMP in platelet adhesion to vascular endotheliumBiochemical and Biophysical Research Communications, 1987
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980